Chawnte Randall passed November 12, 2020
Chawnte is a mother and Army veteran who currently works for the federal government. In October 2017 Chawnte was diagnosed with Stage 2 triple-negative, invasive breast cancer. April 2019, she was diagnosed with Stage 4 metastatic triple-negative breast cancer. Chawnte received radiation therapy for her bone lesions initially but after progression to her liver; Chawnte enrolled in a clinical trial at John’s Hopkins.
Since her initial diagnosis, Chawnte has become an advocate within the breast cancer community and participates in a variety of activities focused on mentoring young women diagnosed with breast cancer. As an African American woman who is living with metastatic breast cancer, Chawnte began to educate herself on the different statistics in the breast cancer community. When she discovered that women of color (African American) were 40% more likely to die or have unfavorable outcomes after a breast or metastatic breast cancer diagnosis, Chawnte was shocked and determined to help change this statistic. Whether it be access to care issues, education issues, monetary issues, and distrust of the medical community due to past historical abuse; all tied together not only yields higher mortality rates but also lower participation in clinical trials. Chawnte hopes to bridge the gap between the medical/scientific community and the breast cancer/metastatic breast cancer community to make effective change to the outcomes disparities for women of color.
Chawnte’ is a Tigerlilly Angel Advocate, LBBC Young Advocate, an individual member of the MBCA and serves on several planning committees for various organizations. She is a co-host for Our MBC Life podcast and part of several patient advocate initiatives. Chawnte’ She also serves on the patient advisory panel for John’s Hopkins and Astra Zeneca.